EBS EQUITY ALERT: Kessler Topaz Meltzer & Check, LLP Announces that a Securities Fraud Class Action Lawsuit was filed on Behalf of Investors of Emergent BioSolutions Inc.


You May Also Like

Corbus Pharmaceuticals Reports 2018 Second Quarter Financial Results and Provides Business Update

Lenabasum has reached Phase 3 clinical stage in two orphan autoimmune indications: systemic sclerosis ...

Confluence Health Latest to Join Greenhealth Exchange

Reston, Virginia, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Greenhealth Exchange (GX)—a purchasing cooperative that ...